Randomized, Single-blind, Placebo-controlled, Escalating Single-dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of Intravenously Administered BAY 1747846 in Japanese Healthy Male Subjects
Latest Information Update: 26 May 2025
At a glance
- Drugs Gadoquatrane (Primary)
- Indications CNS disorders
- Focus Adverse reactions
- Sponsors Bayer
Most Recent Events
- 15 Nov 2023 New trial record